PT Kalbe Farma Tbk. Reports Earnings Results for the Nine Months Ended September 30, 2021
October 24, 2021
Share
PT Kalbe Farma Tbk. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was IDR 19,098,695.08 million compared to IDR 17,095,837.86 million a year ago. Net income was IDR 2,287,734.41 million compared to IDR 2,027,403.7 million a year ago. Basic earnings per share from continuing operations was IDR 48.81 compared to IDR 43.25 a year ago.
PT Kalbe Farma Tbk is an Indonesia-based company, which is engaged in the development, manufacturing and trading of pharmaceutical products including human medicines and consumer health products. Its business divisions include Prescription Pharmaceutical, Consumer Health Division, Nutritionals, and Distribution and Logistic divisions. The Prescription Pharmaceuticals division provides a range of products for all groups, from unbranded generic drugs for the mass-market segment, to branded generics and licensed drugs. The Consumer Health division's product portfolio spans from over the counter (OTC) drugs and energy drinks to a selection of ready-to-drink healthy beverage products. The Nutritional division manages a range of nutritional products, comprising of powdered milk products for all age segments. It also offers a selection of non-milk nutritional products. The Distribution and Logistics Division operates the distribution coverage for pharmaceuticals products in Indonesia.
PT KALBE FARMA TBK. 
